6A7 Stock Overview
Through its subsidiaries, engages in the acquiring and partnering with dental practices to provide health care services in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 6A7 from our risk checks.
dentalcorp Holdings Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$5.90 |
| 52 Week High | CA$6.50 |
| 52 Week Low | CA$3.60 |
| Beta | 1.27 |
| 11 Month Change | 2.61% |
| 3 Month Change | 18.47% |
| 1 Year Change | 60.33% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 44.29% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6A7 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -4.8% | 0.1% | -0.02% |
| 1Y | 60.3% | 17.2% | 8.2% |
Return vs Industry: 6A7 exceeded the German Healthcare industry which returned 17.2% over the past year.
Return vs Market: 6A7 exceeded the German Market which returned 8.2% over the past year.
Price Volatility
| 6A7 volatility | |
|---|---|
| 6A7 Average Weekly Movement | 4.8% |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: 6A7 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 6A7's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 10,100 | Graham Rosenberg | www.dentalcorp.ca/site/home |
dentalcorp Holdings Ltd., through its subsidiaries, engages in the acquiring and partnering with dental practices to provide health care services in Canada. The company was formerly known as Dentalcorp Overbite Ltd. dentalcorp Holdings Ltd.
dentalcorp Holdings Ltd. Fundamentals Summary
| 6A7 fundamental statistics | |
|---|---|
| Market cap | €1.21b |
| Earnings (TTM) | -€55.92m |
| Revenue (TTM) | €1.04b |
1.2x
P/S Ratio-21.7x
P/E RatioIs 6A7 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6A7 income statement (TTM) | |
|---|---|
| Revenue | CA$1.51b |
| Cost of Revenue | CA$769.50m |
| Gross Profit | CA$740.30m |
| Other Expenses | CA$821.70m |
| Earnings | -CA$81.40m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.43 |
| Gross Margin | 49.03% |
| Net Profit Margin | -5.39% |
| Debt/Equity Ratio | 61.3% |
How did 6A7 perform over the long term?
See historical performance and comparison